|
|
.
See Category: Endocrine, nutritional and metabolic diseases
See Header: Type 2 diabetes mellitus with ophthalmic complications
ICD-10 (CM) Code and Descriptor
|
E11.39 |
Type 2 diabetes mellitus with other diabetic ophthalmic complication
|
E1139 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 29.24%
|
16.58%
|
13.33%
|
9.60%
|
7.10%
|
5.49%
|
4.32%
|
3.50%
|
2.53%
|
2.09%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E11.39*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
3,104
|
3,104
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2,443
|
2,451
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2,353
|
2,358
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,790
|
1,791
|
|
80061
|
LIPID PANEL |
1,570
|
1,570
|
|
G0467
|
FQHC VISIT, ESTAB PT |
1,229
|
1,229
|
|
82043
|
UR ALBUMIN QUANTITATIVE |
1,103
|
1,104
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
1,067
|
1,067
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,014
|
1,017
|
|
82570
|
ASSAY OF URINE CREATININE |
831
|
842
|
|
97530
|
THERAPEUTIC ACTIVITIES |
831
|
1,470
|
|
84443
|
ASSAY THYROID STIM HORMONE |
828
|
829
|
|
97110
|
THERAPEUTIC EXERCISES |
767
|
1,316
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
682
|
682
|
|
80048
|
METABOLIC PANEL TOTAL CA |
662
|
663
|
|
82962
|
GLUCOSE BLOOD TEST |
466
|
513
|
|
82306
|
VITAMIN D 25 HYDROXY |
336
|
336
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
326
|
724
|
|
85027
|
COMPLETE CBC AUTOMATED |
308
|
308
|
|
97116
|
GAIT TRAINING THERAPY |
286
|
369
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E11.39 related to the following DRG Codes:
008
010
019
124-125
|
